Blennow K - Search Results

1

CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.

Andreasen N, Sjögren M, Blennow K. Andreasen N, et al. Among authors: blennow k. World J Biol Psychiatry. 2003 Oct;4(4):147-55. doi: 10.1080/15622970310029912. World J Biol Psychiatry. 2003. PMID: 14608585 Review.

2

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.

Heilig M, Sjögren M, Blennow K, Ekman R, Wallin A. Heilig M, et al. Among authors: blennow k. Biol Psychiatry. 1995 Aug 15;38(4):210-6. doi: 10.1016/0006-3223(94)00239-Y. Biol Psychiatry. 1995. PMID: 8547442

3

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Blennow K, et al. Mol Chem Neuropathol. 1995 Dec;26(3):231-45. doi: 10.1007/BF02815140. Mol Chem Neuropathol. 1995. PMID: 8748926

4

Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia.

Wallin A, Edman A, Blennow K, Gottfries CG, Karlsson I, Regland B, Sjögren M. Wallin A, et al. Among authors: blennow k. J Geriatr Psychiatry Neurol. 1996 Oct;9(4):185-99. doi: 10.1177/089198879600900406. J Geriatr Psychiatry Neurol. 1996. PMID: 8970012

5

The neurochemistry of Alzheimer's disease.

Blennow K, Cowburn RF. Blennow K, et al. Acta Neurol Scand Suppl. 1996;168:77-86. doi: 10.1111/j.1600-0404.1996.tb00378.x. Acta Neurol Scand Suppl. 1996. PMID: 8997425 Review.

6

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.

Minthon L, Hesse C, Sjögren M, Englund E, Gustafson L, Blennow K. Minthon L, et al. Among authors: blennow k. Neurosci Lett. 1997 Apr 18;226(1):65-7. doi: 10.1016/s0304-3940(97)00230-9. Neurosci Lett. 1997. PMID: 9153643

7

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Andreasen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, Räihä I, Sourander L, Winblad B, Blennow K. Andreasen N, et al. Among authors: blennow k. J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):298-305. doi: 10.1136/jnnp.64.3.298. J Neurol Neurosurg Psychiatry. 1998. PMID: 9527138 Free PMC article.

8

Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing.

Blennow K, Vanmechelen E. Blennow K, et al. J Neural Transm Suppl. 1998;53:223-35. doi: 10.1007/978-3-7091-6467-9_20. J Neural Transm Suppl. 1998. PMID: 9700660 Review.

9

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.

Sjögren M, Minthon L, Passant U, Blennow K, Wallin A. Sjögren M, et al. Among authors: blennow k. Neurobiol Aging. 1998 Sep-Oct;19(5):379-84. doi: 10.1016/s0197-4580(98)00086-4. Neurobiol Aging. 1998. PMID: 9880039

10

Neurofilament protein levels in CSF are increased in dementia.

Rosengren LE, Karlsson JE, Sjögren M, Blennow K, Wallin A. Rosengren LE, et al. Among authors: blennow k. Neurology. 1999 Mar 23;52(5):1090-3. doi: 10.1212/wnl.52.5.1090. Neurology. 1999. PMID: 10102440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,197 results

Search Page

Filters